Blog

Advancing Therapeutic Delivery Through Trans-Oral Mucosal Technology InstaMed Pharmaceuticals

Tracy Gibbs, PhD InstaMed Chief Scientific OfficerSarah Morgan, MS InstaMed Chief Executive Officer Summary InstaMed™ Pharmaceuticals is pioneering the future of active ingredient delivery for both Rx and Non Rx ingredients. Utilizing a patented ODS (Oral Dissolvable Strip) technology designed for trans-oral mucosal administration, including buccal and sublingual routes, we are providing a method for higher compliance and better user experience. Our technology utilizes the highly vascula …
Feb 15th 2014 Tracy Gibbs, PhD InstaMed Chief Scientific Officer and Sarah Morgan, MS InstaMed Chief Executive Officer
Newsletter

Unlock The Science

Join our newsletter for insights, innovations, and exclusive offers.